Tc-99m-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with Tc-99m-MIBI

Citation
V. Papantoniou et al., Tc-99m-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with Tc-99m-MIBI, EUR J NUCL, 28(7), 2001, pp. 923-928
Citations number
10
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
Journal title
EUROPEAN JOURNAL OF NUCLEAR MEDICINE
ISSN journal
03406997 → ACNP
Volume
28
Issue
7
Year of publication
2001
Pages
923 - 928
Database
ISI
SICI code
0340-6997(200107)28:7<923:TSITAO>2.0.ZU;2-X
Abstract
The purpose of this study was to evaluate and compare the diagnostic accura cy of pentavalent technetium-99m dimercaptosuccinic acid [Tc-99m-(V)DMSA] a nd Tc-99m-methoxyisobutylisonitrile (MIBI) in the detection of primary brea st cancer and metastatic lymph node involvement, and in the clarification o f cases with indeterminate mammograms. Forty-one women (mean age SD 55 +/-7 years) referred for a suspicious breast lesion on physical examination and /or an abnormal mammogram underwent MIBI and (V)DMSA scintimammography (SMM ) at separate sessions (48-h interval). Lateral prone and anterior supine i mages were obtained at 10 and 60 min after administration of 740-925 MBq of each tracer, in the arm contralateral to the breast lesion. The ipsilatera l axillary region was also included in the field of view. The results of SM M and mammography were compared with histological findings. Breast cancer w as histologically confirmed in 26 patients (mean diameter +/- SD 2.87 +/-1. 5 cm). Benign lesions were found in 15 patients (mean diameter +/- SD 2.04 +/-2.7 cm). Mammography was definitely positive in 23/26 patients with brea st cancer and indeterminate in 3/26 (sensitivity 88.4%). In benign lesions, mammography was true negative in 5/15 cases and indeterminate in 10/15 (sp ecificity 33.3%). Both MIBI and (V)DMSA SMM detected 23/26 breast cancers ( sensitivity 88.4%) and were true negative in 14/15 (specificity 93.3%). T/B . ratios for breast cancer in MIBI and (V)DMSA scans were similar, and sign ificantly higher than for benign lesions. MIBI correctly diagnosed 12/13 an d (V)DMSA 11/13 cases in which the findings of mammography were indetermina te. In addition, (V)DMSA detected seven of eight cases of in situ ductal ca rcinoma (DCIS) associated with infiltrating carcinomas, while MIBI detected only two of these eight cases. (V)DSMA was also diffusely concentrated in benign lesions complicated by epithelial hyperplasia. Metastatic lymph node involvement was successfully imaged in 15/19 patients with metastatic dise ase by both agents (sensitivity 78.9%), while true-negative scans were obse rved in 19/22 (specificity 86.3%) patients with benign or malignant tumours . without lymph node metastases. Linear regression analysis revealed a high coefficient of correlation between the (V)DMSA and the MIBI T/B ratios (r= 0.8 P <0.001). We conclude that both (V)DMSA and MIBI show an excellent abi lity to detect breast cancer and its lymph node metastases. (V)DMSA also ha s a tendency to be diffusely and more intensely localised than MIBI in pre- invasive lesions, such as DCIS or epitheliosis, which are at risk of develo ping into malignancies. (V)DMSA could therefore provide a useful tool in th e diagnosis of such lesions and possibly modify a predefined surgical plan. Finally, we believe that both tracers could offer an alternative method fo r elucidating nondiagnostic mammograms.